Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign up Log in
Powered By

FDA Approves First At-Home Brain Neuromodulation Device for Depression

Written by Ted Samson
Posted on March 4, 2026

The U.S. Food and Drug Administration (FDA) recently approved the ProlivRx device as the first prescription, at-home brain neuromodulation therapy for adults with major depressive disorder (MDD) whose symptoms haven’t improved enough with at least one antidepressant.

🗳️ Have you tried neuromodulation therapy for depression, such as electroconvulsive therapy or transcranial magnetic stimulation?
Yes, and it helped.
Yes, but it didn’t help.
No, but I am interested.
No, and I am not interested.

The approval means that people living with depression who don’t get enough relief from antidepressant medications now have an additional treatment option.

What Is ProlivRx?

ProlivRx is a wearable headset designed for people living with depression who have tried at least one antidepressant without enough improvement. It’s worn on the head and controlled via a smartphone app.

ProlivRx is a wearable device that sends gentle electrical pulses to specific nerves to relieve symptoms of depression. (Neurorelief)

Unlike transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT) treatments that require visits to a doctor’s office, ProlivRx can be used at home, but it still needs a doctor’s prescription and supervision.

The device works by sending gentle electrical pulses to specific nerves in the head, the occipital and trigeminal nerves. These nerves help regulate brain areas involved in mood, stress, and emotional response. The goal is to help “reset” the brain circuits linked to depression symptoms, offering a nondrug alternative for people who haven’t gotten enough help from medication.

What Did the Clinical Study Find?

The FDA approval was based on results from a large clinical trial called the MOOD Study. This study included 124 adults with MDD who hadn’t responded well to antidepressants. They were randomly assigned to use either ProlivRx or a similar-looking placebo device for eight weeks, while continuing their medication.

Among the study findings:

  • After eight weeks, people using the real device had a greater reduction in depression symptoms (an average of 8.6 points on the Hamilton Depression Rating Scale) compared to those using the sham device (6 points).
  • Remission rates (meaning very low or no depression symptoms) were higher with ProlivRx (about 21 percent) than with sham treatment (6 percent).
  • People who kept using the device for a total of 16 weeks saw continued improvements, with nearly one-third reaching remission by the end of the study.

These improvements are similar to or better than those seen in studies of other device-based depression treatments, such as TMS, especially for people who haven’t found enough relief with medication alone.

Side Effects and Safety

The most common side effects reported in the clinical study were mild and temporary. These included:

  • Headaches or discomfort where the device contacts the skin
  • Skin discoloration or mild irritation
  • Rarely, worsening depression symptoms (which were monitored and managed by the study team)

No serious or unexpected device-related side effects were reported, and most people were able to complete the study as planned. As with any new treatment, ongoing monitoring and real-world experience will help clarify long-term safety.

What This Means for People With Depression

For people living with depression who have not found enough relief with medication, the FDA approval of ProlivRx may offer a new treatment pathway. This device is not meant to replace antidepressants, but it may be used alongside them. It also provides a potential option for people who need a nondrug, noninvasive alternative or who face barriers to accessing traditional clinic-based therapies.

ProlivRx is expected to become available in the U.S. in 2026 through authorized prescribers.

If you’re not satisfied with your current depression treatment, talk with your healthcare provider about your options. They can help you weigh the benefits and risks of different treatments — including new devices, medications, therapy, and lifestyle changes — to find the plan that works best for you.

Join the Conversation

On MyDepressionTeam, people share their experiences with depression and related conditions, get advice, and find support from others who understand.

Have you tried neuromodulation devices for depression? Let others know in the comments below.

All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
233,489 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
233,489 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use

Thank you for subscribing!

Become a member to get even more

See answer